This document is page 20 of a Cannabis Investment Report dated December 2017, produced by Ackrell Capital, LLC. It details scientific information regarding cannabinoids, specifically contrasting THC and CBD, and provides a matrix of medical conditions (such as Cancer, ALS, and Glaucoma) alongside the specific cannabinoids used to treat them. The document bears a 'HOUSE_OVERSIGHT_024656' Bates stamp, indicating it was part of a document production for the House Oversight Committee, though the text itself contains no direct references to Jeffrey Epstein or his associates.
| Name | Type | Context |
|---|---|---|
| Ackrell Capital, LLC | ||
| FINRA | ||
| SIPC | ||
| House Oversight Committee |
| Location | Context |
|---|---|
"Cannabinoids are compounds present in the cannabis plant that act on human cannabinoid receptors in cells in the nervous and immune systems."Source
"Generally, the most abundant cannabinoid is THC, a psychoactive compound that causes a euphoric 'high,' and the second most abundant cannabinoid is cannabidiol, or CBD, which produces a relaxing physical effect without a psychoactive effect."Source
"THC is the most abundant cannabinoid in cannabis and is understood to be the psychoactive compound in cannabis primarily responsible for the euphoric feeling of being 'high.'"Source
Complete text extracted from the document (2,092 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document